779404006: Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Product containing only glycopyrronium and neostigmine (medicinal product)\Glycopyrronium and neostigmine only product in parenteral dose form
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing glycopyrronium (medicinal product)\Glycopyrronium- and neostigmine-containing product\Product containing only glycopyrronium and neostigmine (medicinal product)\Glycopyrronium and neostigmine only product in parenteral dose form
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing glycopyrronium (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing glycopyrronium (medicinal product)\Product containing glycopyrronium in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing quaternary ammonium compound (product)\Product containing glycopyrronium (medicinal product)\...

\Glycopyrronium- and neostigmine-containing product\Product containing only glycopyrronium and neostigmine (medicinal product)\Glycopyrronium and neostigmine only product in parenteral dose form
\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form

\Product containing glycopyrronium in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form

\Product manufactured as parenteral dose form\Product containing glycopyrronium in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form
\Product manufactured as parenteral dose form\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form

\Autonomic drug (substance)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Product containing only glycopyrronium and neostigmine (medicinal product)\Glycopyrronium and neostigmine only product in parenteral dose form
\Autonomic drug (substance)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form
\Autonomic drug (substance)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form
\Autonomic drug (substance)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing glycopyrronium (medicinal product)\Glycopyrronium- and neostigmine-containing product\Product containing only glycopyrronium and neostigmine (medicinal product)\Glycopyrronium and neostigmine only product in parenteral dose form
\Autonomic drug (substance)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing glycopyrronium (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form
\Autonomic drug (substance)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Product containing glycopyrronium (medicinal product)\Product containing glycopyrronium in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3740505016 Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3740506015 Glycopyrronium and neostigmine only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3740505016 Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3740506015 Glycopyrronium and neostigmine only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5564281000241114 produit contenant seulement du glycopyrronium et de la néostigmine sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

5564281000241114 produit contenant seulement du glycopyrronium et de la néostigmine sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Glycopyrronium and neostigmine only product in parenteral dose form	Count of base of active ingredient	deux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Glycopyrronium and neostigmine only product in parenteral dose form	Has manufactured dose form	Parenteral dose form (dose form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Glycopyrronium and neostigmine only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Neostigmine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Glycopyrronium and neostigmine only product in parenteral dose form	Is a	Product containing only glycopyrronium and neostigmine (medicinal product)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Glycopyrronium and neostigmine only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Glycopyrronium (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Glycopyrronium and neostigmine only product in parenteral dose form	Is a	Glycopyrronium- and neostigmine-containing product in parenteral dose form	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Is a	True	Glycopyrronium and neostigmine only product in parenteral dose form	Inferred relationship	Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3740505016	Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3740506015	Glycopyrronium and neostigmine only product in parenteral dose form	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3740505016	Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3740506015	Glycopyrronium and neostigmine only product in parenteral dose form	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5564281000241114	produit contenant seulement du glycopyrronium et de la néostigmine sous forme parentérale	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
5564281000241114	produit contenant seulement du glycopyrronium et de la néostigmine sous forme parentérale	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module